Oramed Pharmaceuticals (Israel) Backtesting

ORMP -- Israel Stock  

null 1,240  13.00  1.04%

With this equity back-testing module your can estimate the performance of a buy and hold strategy of Oramed Pharmaceuticals and determine expected loss or profit from investing in Oramed Pharmaceuticals over given investment horizon. Additionally take a look at Your Equity Center.
Horizon     30 Days    Login   to change
SymbolX
Backtest

Search Suggestions

OROsisko Gold Royalties LtdStock
IXORIX CorporationStock
OAOrbital ATKStock
OBGRFOrbit Garant DrillingStock
OBTEFORBITAL CORP LTDStock
OCLDFOrica LimitedStock
OCLCFOracle Corporation JapanStock
OCLDYOrica LimitedStock
OCSIXOrchard Small Cap Value IFund
OCSNXOrchard Small Cap Value NFund
OECOrion Engineered Carbons S AStock

Current Sentiment - ORMP

Oramed Pharmaceuticals Investor Sentiment

Macroaxis portfolio users are evenly split in their perspective on investing in Oramed Pharmaceuticals. What is your perspective on investing in Oramed Pharmaceuticals? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally take a look at Your Equity Center. Please also try Crypto Portfolio Optimizer module to optimize portfolio of digital coins and token across multiple currency and exchanges.
Search macroaxis.com